The Kety-Schmidt nitrous oxide method (2) is presently the only well-accepted technique for the quantitative estimation of human cerebral perfusion. In spite of theoretical objections (3) and practical limitations it has provided a wealth of otherwise unobtainable information. The procedure is tedious, however, and has remained predominantly a laboratory research tool.
The Kety-Schmidt nitrous oxide method (2) is presently the only well-accepted technique for the quantitative estimation of human cerebral perfusion. In spite of theoretical objections (3) and practical limitations it has provided a wealth of otherwise unobtainable information. The procedure is tedious, however, and has remained predominantly a laboratory research tool.
Efforts have continued to find an accurate, more adaptable method, but with limited success. Sapirstein and Hanusek (4) (5) (6) have reported measurements of regional blood flow in laboratory animals by use of K42, Rb86, and 4-iodo831 antipyrine, and Sapirstein has reported observations concerning the applicability of these materials to measurement of human cerebral perfusion (7, 8) . This investigation was designed to evaluate, clarify, and extend those observations by employing 4-iodo'8lantipyrine and Rb86Cl in the quantitative estimations of human cerebral blood flow. The effects of altered arterial pCO2 upon cerebral hemodynamics were evaluated by use of this research method.
THEORETICAL CONSIDERATIONS
Regional blood flow by indicator distribution. After a rapid intravenous injection of an indicator substance, mixing occurs during passage through the central circulation. The initial distribution throughout the body is directly proportional to the regional distribution of the cardiac output. The problem inherent in this method of determining organ blood flow is that of quantifying the fraction of injected indicator received by an organ during this first circulation. It would be fortunate if a substance existed that could be totally extracted by each organ through which it passed; problems dealing with recirculation would be avoided. With such a substance, organ content would increase as the arterial bolus was delivered, and since venous drainage of the substance would be zero, the organ content after initial localization would be independent of time. In that case the fractional organ uptake of the injected dose would be proportional to the fractional organ distribution of the cardiac output. Sources for error in this theoretical system would be the presence of pulmonary indicator losses and arteriovenous shunts.
It would be possible to make measurements of regional blood flow, however, if the substance became redistributed sufficiently slowly after initial localization. This might allow extrapolation of the organ washout rate back to maximal organ content at zero time of initial delivery. Sapirstein (4) has reported that the net redistribution rate for K42 and Rb86 after initial localization of a bolus injection for most organs of the rat and dog is slow enough not to be statistically detectable for 3 minutes. The applicability of these isotopes to measurement of regional blood flow probably depends on the nature of the distribution of body potassium and the rate of membrane ion transport. Walker and Wilde (9) have demonstrated -that the injected isotope bolus of K'2 of high specific activity, which is initially diluted in a relatively small blood volume, is to a large degree lost from the vascular compartment after the first circulation has washed through. Since the organ content is initially zero and the arterial bolus concentration is high, the tracer is transferred chiefly into the organ pool, since it is considerably larger than the vascular reservoir for potassium. Most of the radioactivity is rapidly cleared from the circulation, and the remainder is diluted. Net redistribution is slow, and for a considerable period after the first circulation of the bolus, the organ fraction of the injected dose reflects the fractional organ distribution of the cardiac output. The washout curve approaches a relatively horizontal line.
The major objection to this method for measuring regional blood flow in animals is that the entire time-course of localization cannot be viewed, since the organs must be removed for counting purposes. Early redistribution from regions with small exchangeable pools-e.g., brain-or from arteriovenous shunts give falsely low flow fractions for these organs. Conversely, there are false increases in the flow fractions to organs with large exchangeable pools, owing to the redistribution of the tracer out of proportion to the initial distribution of the cardiac output. This objection would be removed if the organ content could be continuously observed during accumulation of the tracer ( 10) . In that case, early redistribution could be detected and possibly corrected for by extrapolation.
Cerebral blood flow. The principles of this method have been applied to the quantification of human cerebral blood flow (1, 7, 8) . In order to measure uptake by an organ of a radioisotope in vivo, it is necesary to observe the organ quantitatively with appropriate detectors. Gamma emission from the human brain has not been satisfactorily separated from that of adjacent noncerebral cephalic structures. For the present, therefore, it has been necessary to determine cerebral blood flow from the difference between the total cephalic flow-brain, head, and neck-and the noncerebral cephalic flow-head and neck. 4-Iodo13'antipyrine and Rb86Cl have been used to measure total cephalic blood flow and noncerebral cephalic blood flow, respectively.
Total cephalic blood flowe. Sapirstein and Hanusek (6), Hansen (11) , and Reinmuth and Scheinberg (12) have reported that 4-iodo13l-antipyrine readily crosses the "blood-brain barrier." During the first circulation after a venous injection of 4-iodo13'antipyrine, the quantity delivered to the head represents the cephalic fractional distribution of the cardiac output. There is a reasonably large, exchangeable, cephalic reservoir for the isotope, and the washout rate after initial localization is relatively slow (Figure 1 ; the rate meter time constant is 2.0 seconds).
The arteriovenous differences for 4-iodo3'3-antipyrine were determined in two subjects in order further to elucidate the nature of the cephalic distribution and washout of the isotope. Samples were taken from the brachial artery and the internal jugular vein by retrograde arm vein catheterization with fluoroscopic placement of the catheter tip just cephalad to the junction with the subclavian vein at the base of the neck. At this point the internal jugular vein has received a major portion of the venous drainage from the head and neck (13) . The arterial and venous concentration changes with time are shown for one of these subjects during the minute and a half after central velOtos (superior vena cava) injection (Figure 2 ). The arterial concentration describes an indicator dilution curve. The venous curve gradually increases during the first circulation, and it then remains slightly above the arterial concentration 2222 during the subsequent minute of observation. The venous blood demonstrates significant concentration of label during the period of observation, and this accounts for the early redistribution of the cephalic 4-iodo103antipyrine. A large portion of the tracer delivered by the arterial blood is retained by the head, and redistribution is relatively slow.
Mathematical model. Since significant cephalic washout of 4-iodo131antipyrine-approximately 15 to 20 per cent-occurs during initial localization, it is necessary to compute the value for cephalic content existing before washout has occurred. In order to make this calculation, a model has been devised that requires several simplifying assumptions. The heart is represented by a single chamber of fixed volume whose contents are uniformly and instantly labeled at the moment of injection. Flow of blood through the chamber is constant for the period of observation. A portion, A,, of the uniformly labeled pool at zero time is destined for the head. The quantity of label in the heart destined for the cephalic structures at time t is A1t. From this is derived Equation 1,
The head is assumed to be a single, fixed-volume mixing chamber that accumulates indicator as it leaves the heart. Distortion imposed by passage through the arteries leading to the head is considered negligible. Consequently, cephalic uptake can be represented as a first-order exponential function.
However, the experimental observations (Figure 1) show significant washout during localization. This is assumed to follow a first-order exponential function. The rate of change of cephalic 6, 000 . 
where Qt is an approximation of the cardiac label still to be delivered to the head at time t and is represented in Figure 3 by the line L1. I that of the vascular compartment. In addition, the initial bolus is delivered in a volume considerably less than the total vascular volume. Therefore, the contribution from recirculating label at any time must represent only a small portion of the amount initially delivered to the cephalic compartment.
The error introduced for the value of the cephalic portion A,0 of the cardiac indicator by use of the value for K1AQ/K1 -K2 was found to be 2.5 + 0.4 per cent in 9 experiments in 5 subjects. This was considered to be sufficiently good for the purposes of this investigation. If greater accuracy is required, A, could be determined from the coordinate K1Ao/K, -K2, and from the values obtained for K1 and K2 by standard methods for analysis of the semilogarithmic plot of the observed data.
Noncerebral cephalic blood flow. The noncerebral cephalic fraction of the cardiac output is determined from an injection of Rb86Cl. After a rapid central venous injection of the label, the cephalic count rate describes an indicator dilution curve (Figure 4 ), and then a plateau for a considerable time. Since there is virtually no readily exchangeable cerebral reservoir for cationic materials, the indicator dilution pattern seen initially represents shunting of the isotope through the brain. There is, however, a large, rapidly exchangeable reservoir for Rb06 in non-nervous tissue (5, 9) , and after the first circulation has washed through, the residual cephalic plateau is greater than 10 per cent of the injected dose. This probably does not represent an appreciable number of counts from the vascular compartment, since the apparent minute volume of distribution averages somewhat more than 60 L, and cephalic blood volume appears to be relatively small. The stable cephalic plateau, therefore, represents the approximate noncerebral cephalic fraction of the cardiac output.
Two problems exist in the interpretation of the exact nature of the cephalic Rb86 plateau after initial localization of the injected dose. The second major objection to this method for determining regional blood flow is the large cerebral shunt for Rb86, i.e., the effects of arteriovenous shunts upon the redistribution of the injected dose out of proportion to the initial distribution of the cardiac output. It is readily seen from the cephalic Rb86 count rate (Figure 4 ) that the brain represents a substantial shunt whose Rb86 content must be redistributed to organs with exchangeable pools during subsequent circulations. Sheppard, Overman, Wilde, and Sangren (14) have reported that in the dog the major organs except for the brain-liver, kidney, and extremity-exhibit little shunting for K42. Thus, the material recirculated from the brain probably makes up the greatest portion of the total body shunt. In that case, the noncerebral cephalic fraction of the cardiac output is overestimated by the fraction of Rb86 redistributed to it from the Rb8i6 shunt in propor- tion to the noncerebral cephalic blood flow. It was assumed that the only major shunt different for Rb86 and 4-iodo13tantipyrine was represented by the brain. Therefore, the noncerebral cephalic blood flow is the cephalic fraction of the injected Rb86-less the cerebral Rb86 residue, assumed to be zero for this investigation-multipled by the cardiac output, and is overestimated by the redistribution of the cerebral flow fraction to noncerebral cephalic structures in proportion to the noncerebral cephalic flow. Cerebral blood flow is the difference between the total cephalic blood flow-determined from the zero-time maximal content of the cephalic 4-iodo131antipyrine multiplied by the cardiac output-and the noncerebral cephalic fraction, multiplied by cardiac output and corrected for the recirculation of Rb86 from the brain shunt to the noncerebral cephalic structures in proportion to the noncerebral cephalic blood flow. Sapirstein's report (8) Isotopes. Approximately 20 Ac of Rb'Cl 1 of high specific activity in 2 ml isotonic saline was injected and the count rate recorded for 2 min. Four to 6 Atc of 4-iodo1"'antipyrinel in 2 ml isotonic saline was then injected and the count rate recorded. 2 The purity of the 4-iodo"t'antipyrine was checked by a paper chromatographic separation in a 1: 1 ethanol: toluene solvent system. Strips were scanned for distribution of radioactivity. Ninety-five to 98 per cent of the activity migrated with an Rf of 0.95 (15) during the useful life of the isotope.
Isotope counting equipment. The detector is a gammaray-sensitive, bismuth-tube well sufficiently large to contain the human head (Nucleonic Corporation of America). The background count rate with shielding is 2,500 cpm. The well is surrounded by 2 inches of lead, and has a movable lead collar at the orifice that excludes virtually all radiation emanating from below the subject's neck, except for a small region at the base of the neck ( Figure 6 ). The count rate of a dose of either Rb56 or 4-iodo13lantipyrine from the orifice in the collar, as comp)ared to the count rate wvithin the well, was less than 2 per cent.
The position of the subject's head within the well is critical, particularly since count rate is inversely proportional to the square of the distance, and the dimensions of this counting system are large. It was necessary to place each subject in the same position as the calibrating phantom, since motion within the well near the orifice where the head and neck were confined altered the count rate significantly.
Count rates were recorded through a linear rate meter (Nuclear-Chicago model 1510A) onto a strip chart recorder at 6 inches per minute (Texas Instrument Company).
Calibrating standard. The standards were prepared by making duplicate injections of the isotopes into 100-ml volumetric flasks through the venous inj ection catheter (100 per cent standard). A known fraction of the substance for injection was placed in a "standard" waterfilled phantom head (16) , and quantification of the cephalic fraction of the injected dose was performed by comparing the cephalic count rates with the count rate of the phantom (Figure 6 ). In this system, the count rate was relatively independent of the isotope distribution within the phantom. For example, when RbV was placed in the periphery of the phantom, with the center portion taken up by a water-filled balloon, the count rates vere not different. This is probably the result of several simultaneously operating variables such as changes in distance, radiation absorption and scattering in the fluid medium, and end loss from the detector. The phantom, however, was not satisfactory unless it contained a neck piece, since 20 per cent of the total counts observed within the well were counted in a sample placed externally in the position of the neck. Although the size of the phantom takes no account of individual variations in head size, fluid volumes from 4 to 6 L had no effect upon the total count rate. Uneven isotope distribution within the human brain, however, may contribute to error in quantification of the cephalic flow fraction. This will require further evaluation, particularly in disease states where large areas may lack adequate perfusion.
Cardiac output. Cardiac output was measured by use of the indicator dilution principle (17) (20) .
.4rterial pressure and vascular resistance. Mean arterial pressure was recorded with the reference point in the second intercostal space at the mid-chest with a Statham p23G strain gauge coupled to a carrier amplifier and direct-writing recorder (Sanborn model 150).
Total peripheral resistance (TPR) was calculated from the following relationship: TPR (dyne-sec-cm-') = [Mean arterial blood pressure (mm Hg) X 1,332]/ cardiac output (ml per sec). The contribution of left atrial pressure was ignored (21) . Cerebral vascular resistance was calculated from a similar relationship by substituting cerebral blood flow in milliliters per second for cardiac output and omitting the correction for jugular venous pressure. cerebral fraction of the cardiac output, averaged termination in 5 of the subjects. Replicate resting 709 ± 178 ml per min. These results agree with determinations were performed within 20 minutes those reported by use of the Kety-Schmidt nitrous in the same manner as the initial determination. oxide method (2, 22) . The coefficient of correlation for each parameter Table II demonstrates the reliability of the de-measured is presented with the t test of significance Tables III, IV , and V show the effects of altered arterial pCO2 upon cardiac output and cerebral hemodynamics. Voluntary hyperventilation diminished mean arterial pCO2 to 20 mm Hg and increased arterial pH to 7.60. Cardiac output significantly increased 1.06 L per minute, and the cerebral fraction of the cardiac output was reduced from a normal value of 12.5 ± 1.2 to 6.3 + 2.3 per cent. The cerebral blood flow fell from 681 ± 119 to 419 ± 201 ml per minute. Although total peripheral resistance fell slightly, the cerebrovascular resistance approximately doubled. Inhaling 5 per cent CO2 in air for 10 minutes increased arterial PCO2 5 mm Hg and cardiac output 440 ml per minute. The cerebral fraction of the cardiac output increased from 13.2 ± 3.1 to 14.5 ± 2.9 per cent. Thus the cerebral blood flow increased from 757 + 196 to 906 ± 223 ml per minute. The results for CO2 inhalation demonstrate an increase in total cerebral blood flow as well as a greater cerebral distribution of the cardiac output. Although total vascular resistance remained essentially unchanged, there was a decrease in cerebrovascular resistance. The significance of the observed differences was determined with each subject serving-as his own control (22) .
RESULTS

DISCUSSION
The exchangeable cephalic reservoir for 4-iodo13lantipyrine is sufficiently large that early net redistribution is slow, and the initial washout can be readily extrapolated toward zero time of organ localization. The fact that 4-iodo13lantipy-rine does not equilibrate with body water, but is concentrated in the liver (24), probably does not alter the initial arterial distribution during the first minute after injection. Sapirstein has reported (8) that the cephalic uptake of 4-iodo'31antipyrine remains relatively constant in man after initial localization, thereby simplifying the extrapolation to maximal organ content. This is presumed to be due to the similarity of the cephalic extraction ratio and the extraction ratio for the rest of the body rather than to zero washout. In preliminary studies in resting subjects, the values reported for the cerebral fraction of the cardiac output could not be confirmed without using a shielded well and a geometrically proportioned phantom head and neck. Lack of suitable shielding (8) also obscured the cephalic washout, demonstrated in all studies reported here, by failing to exclude the body contribution to the well. The concept of similar extraction ratios for the head and body does not appear to be experimentally correct nor theoretically sound. This circumstance could only occur at a unique combination of flow rates. Alterations in flow rates to any organ, or different combinations of flow rates in different subjects would probably disturb any balance that might exist coincidentally. Only in the situation where organs could appropriately change their extraction ratios with changes in flow would equal extraction by head and body be likely to be meaningful, and there is no evidence that this phenomenon occurs.
It would seem more reasonable to describe the relatively slow net redistribution of the cephalic indicator content in terms of the size of the exchangeable pool available for dispersion of 4-iodo131-antipyrine. The volume of distribution is considerably greater than the volume of -the vascular compartment, and the cephalic distribution pool is considerably larger than the available pool within the vascular compartment perfusing the head at any one time. Thus, the washout rate would reasonably depend upon several factors, including the rate of perfusion, the arterial concentration of indicator, and the relative pool sizes available within the exchanging regions of the organ and the vascular compartment perfusing those regions.
To simplify the calculation of maximal cephalic content, AO, of 4-iodo131antipyrine at zero time, we elected to use the graphical approximation that introduced a 2.5 per cent error in the calculation.
Rlecalculation of the control values for cerebral b)lood flow in 16 subjects from the formulation of the true, maximal 4-iodo"''antipyrine content reduced the cephalic fraction from 21.4 to 20.9 per cent of the cardiac output. The mean total flow was reduced to 667 from 709 ml per min. This lower value agrees with the estimates made by the nitrous oxide method with extrapolation to infinite time (25) .
At present, the major experimentally unvalidated assumption involves the empirical acceptance of negligible loss or rapid destruction of the 4-iodo131antipyrine during the initial pulmonary passage. Since the pulmonary reservoir in general is small for most substances, only a modest loss of 4-iodo13lantipyrine probably occurs, even if equilibration with lung tissue is complete.
Sapirstein and Hanusek (6) have reported that, at least for the rat, there is a period during the latter part of the first pulmonary 4-iodo13lantipy-rine passage that the residue represents 7 per cent of the injected dose. He states, however, that this is rapidly washed out. Even a loss this great would only introduce a minimal error in the calculation of total cephalic blood flow. This question is difficult to answer experimentally in man, and has not been effectively evaluated to date. The similarity, however, of the results reported for this study to those reported by an accepted method of estimating human cerebral perfusion tends to confirm the validity of the assumption.
The net redistribution of Rb86Cl is sufficiently slow that organ uptake is approximately representative of functional regional perfusion. This appears to be valid for a considerably longer period than for 4-iodo131antipyrine, probably because of the greater extravascular pool for Rb86. The brain is a significant exception, since there is virtually no exchangeable cerebral Rb86 pool (< 0.5 per cent injected dose). The redistribution of the cerebral Rb86 fraction causes an overestimation of the noncerebral cephalic flow because it is taken up out of proportion to the initial distribution of the cardiac output during subsequent recirculations. To correct for this redistribution, it must be assumed that the brain represents the sole source of this redistribution fraction. This assumption cannot be wholly valid, since there are regions of nervous tissue, with blood supply, not observed by the well. Probably neither the quantity of this tissue nor its rate of perfusion is sufficient for major concern. The correction for the redistribution of Rb86 to the noncerebral cephalic structures represents approximately 10 per cent of the total cephalic Rb86 uptake, and therefore would only slightly alter the final calculations if it were underestimated. The pulmonary indicator losses for K42 and Rb86 have been variously reported between 1.9 and 2.7 per cent of the injected dose in rats, dogs, and rabbits (6, 9, 14) , and therefore represent negligible error.
The values calculated for cerebral blood flow during rest, voluntary hyperventilation, and breathing 5 per cent CO2 in air agree closely with those previously reported by use of the Fick principle and inert gas exchange (2, 22) . Hyperventilation resulted in a significant decrease in total peripheral vascular resistance. The cerebral vessels exhibit marked vasoconstriction, and total cerebrovascular resistance doubled. Five per cent CO, inhalation minimally increased cardiac output and did not alter total calculated peripheral resistance. The cerebral resistance vessels dilated, however, as shown by a significant reduction of total cerebrovascular resistance.
This investigation describes a method for rapid, quantitative measurement of total cerebral blood flow as the fraction of the cardiac output. The technique requires the steady state only for the period of data generation. The measurements may be easily repeated. Equipment has been designed that may allow for the simultaneous determination of all three parameters required to determine cerebral flow by this technique. A permanent record could then be produced every 2 minutes and be reduced electronically to final form.
SUM MARY
The initial distribution of 4-iodo131antipyrine is used to estimate the total cephalic fraction-brain, head, and neck-of the cardiac output. Since there is no readily exchangeable cerebral Rb86 reservoir, and since there is a large, rapidly exchangeable, noncerebral cephalic pool, the stable cephalic content of Rb86Cl corrected for recirculation is used to estimate the noncerebral cephalic fraction-just head and neck-of the cardiac output. The difference between the total cephalic flow fraction and the noncerebral cephalic flow fraction represents the total cerebral blood flow fraction, which when multiplied by cardiac output, determines the total cerebral blood flow.
The effects of voluntary hyperventilation and breathing 5 per cent CO2 in air upon cardiac output, cerebral blood flow, and cerebral vascular resistance were evaluated with this technique. Voluntary hyperventilation increased cardiac output, reduced cerebral blood flow, and doubled cerebrovascular resistance. Five per cent CO2 minimally increased cardiac output, increased cerebral blood flow, and significantly reduced cerebrovascular resistance. These results agree with those reported by the nitrous oxide method, but have the advantage of estimating total cerebral blood flow as a fraction of the cardiac output.
